Browse 43 Therapeutics companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Leal Therapeutics develops novel therapeutics for patients.
Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.
Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.
ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.
BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.
Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.
Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.
Stratus Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.
SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.
Brenig Therapeutics develops therapies for neurodegenerative disorders.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
View all companies funded by OrbiMed across every industry and funding stage.
View Full OrbiMed Portfolio